Cargando…

Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience

Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegde, Arun, Dorji, Thinley, Asturkar, Vikram, Yangzom, Sonam, Bhanu, Kovilapu Uday
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928371/
https://www.ncbi.nlm.nih.gov/pubmed/35308057
http://dx.doi.org/10.1177/2050313X221085099
_version_ 1784670627462905856
author Hegde, Arun
Dorji, Thinley
Asturkar, Vikram
Yangzom, Sonam
Bhanu, Kovilapu Uday
author_facet Hegde, Arun
Dorji, Thinley
Asturkar, Vikram
Yangzom, Sonam
Bhanu, Kovilapu Uday
author_sort Hegde, Arun
collection PubMed
description Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of multiple organ systems often posing a diagnostic challenge. There is a paucity of literature on the myriad presentations of catastrophic anti-phospholipid syndrome owing to the orphan nature of the disease. We present three cases of catastrophic anti-phospholipid syndrome in patients with systemic lupus erythematosus that presented with episodes of thrombosis involving both arterial and venous systems and multisystem organ failure. Timely diagnoses were made based on a high index of suspicion and were managed with a combination of systemic glucocorticoids, cyclophosphamide, plasmapheresis, intravenous immunoglobulin and other supportive measures. However, despite providing the standard of care, we encountered a poor outcome in two of these patients, highlighting the high mortality associated with catastrophic anti-phospholipid syndrome.
format Online
Article
Text
id pubmed-8928371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-89283712022-03-18 Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience Hegde, Arun Dorji, Thinley Asturkar, Vikram Yangzom, Sonam Bhanu, Kovilapu Uday SAGE Open Med Case Rep Case Report Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of multiple organ systems often posing a diagnostic challenge. There is a paucity of literature on the myriad presentations of catastrophic anti-phospholipid syndrome owing to the orphan nature of the disease. We present three cases of catastrophic anti-phospholipid syndrome in patients with systemic lupus erythematosus that presented with episodes of thrombosis involving both arterial and venous systems and multisystem organ failure. Timely diagnoses were made based on a high index of suspicion and were managed with a combination of systemic glucocorticoids, cyclophosphamide, plasmapheresis, intravenous immunoglobulin and other supportive measures. However, despite providing the standard of care, we encountered a poor outcome in two of these patients, highlighting the high mortality associated with catastrophic anti-phospholipid syndrome. SAGE Publications 2022-03-15 /pmc/articles/PMC8928371/ /pubmed/35308057 http://dx.doi.org/10.1177/2050313X221085099 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Hegde, Arun
Dorji, Thinley
Asturkar, Vikram
Yangzom, Sonam
Bhanu, Kovilapu Uday
Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title_full Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title_fullStr Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title_full_unstemmed Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title_short Cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: An experience
title_sort cases of catastrophic anti-phospholipid syndrome in systemic lupus erythematosus: an experience
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928371/
https://www.ncbi.nlm.nih.gov/pubmed/35308057
http://dx.doi.org/10.1177/2050313X221085099
work_keys_str_mv AT hegdearun casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience
AT dorjithinley casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience
AT asturkarvikram casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience
AT yangzomsonam casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience
AT bhanukovilapuuday casesofcatastrophicantiphospholipidsyndromeinsystemiclupuserythematosusanexperience